Optimistic growth of the healthcare sector has resulted in a transition towards value-based business in order to improve patient success and outcome. This aspect has acquired a centre stage as healthcare professionals strive towards shunning postoperative complexities, for instance abrasion formations. Against this backdrop, it becomes imperative to use an adhesion barrier to reduce postoperative pain, bowel obstruction, and female infertility. This has created a positive influence on the adhesion barrier market worldwide.
Demand of Adhesion Barrier in Gynaecological Surgeries to Remain Bullish; Abdominal and Cardiovascular Surgeries to Present Potential Opportunities
Growing demand for adhesion barrier in gynaecological surgeries continues to remain instrumental in driving sales. Increasing adoption of gel and film type adhesion barrier across various applications, particularly gynaecological surgeries such as ovarian cystectomy, endometriosis surgery, and ectopic pregnancy is likely to complement adhesion barrier market growth. Moreover, increasing number of abdominal surgeries is also expected to influence use of adhesion barrier, in turn paving potential avenues of growth for adhesion barrier market.
Conversely, increasing cardiovascular diseases (CVD) are also influencing use of adhesion barriers. According to Centers for Disease Control and Prevention (CDC), every 37 seconds 1 death is recorded in the United States due to cardiovascular disorders. On the global front, more than 17 million mortalities due to CVD are witnessed making CVD one of the major death causes according to the World Health Organization (WHO). This is likely to play a vital role in paving a new opportunity with respect to use of adhesion barrier in cardiovascular surgeries in the following years.
Synthetic Adhesion Barrier to Gain High Ground in Adhesion Barrier Market
Demand for synthetic adhesion barriers is anticipated to grow at a noteworthy pace in the coming years. This can be attributed towards their perceived benefits such as higher biocompatibility and bioresorbable properties. In addition, higher commercial availability of various synthetic adhesion barriers such as hyaluronic acid coupled with their cost-effective nature is expected to drive their sales across various applications, in turn contributing to the overall valuation of the adhesion barrier market. Among all synthetic adhesion barriers, hyaluronic acid is likely to gain high traction on the back of its ability to draw and hold high quantity of moisture.
North America Likely to Lead Adhesion Barrier Market; Europe to Follow Suit
North America is expected to account for a significant share in the adhesion barrier market. Increasing surgery rate across developed economies in North America continue to influence the growth of the adhesion barrier market in the region. Technological advancements along with favourable reimbursement models to incentivize complicated surgeries in the region are few of the key factors driving sales of various adhesion barriers. In addition, use of an adhesion barrier can significantly shun the risks associated with postoperative complications in patients. This has encouraged new developments and innovations in the product, consequently driving growth of the adhesion barrier market in North America.
On the other hand, adhesion barrier market in Europe is poised to remain on the second spot apropos to valuation and growth rate, backed by increase in abdominal surgeries. According to the European Union, increase in abdominal surgeries was witnessed that reached a count of 1.4 million in 2017, an 8% increase than those witnessed in 2016. This number is expected to further increase in the following years, in turn providing ample growth opportunities for the adhesion barrier market.
Adhesion Barrier Market: Competitive Landscape
Key players in the adhesion barrier market continue to focus on growth strategies to ensure increased penetration of their adhesion barrier products across various applications. In parallel, rising healthcare initiatives and infrastructure coupled with increasing entry of new entrants has influenced the market’s growth. Companies are focused on new product development and launches to maintain their position in the highly consolidated adhesion barrier market.
For instance, in 2018, FzioMed, a privately held U.S. company, launched Oxiplex/IU, a new adhesion barrier that is widely used in intrauterine surgeries. Likewise, in 2022, Gunze Limited announced the launch of TENALEAF, an absorbable adhesion barrier that can be used during minimally invasive surgery and in open surgeries to provide better adhesion strength. The company plans to mass produce this novelty and has acquired distribution rights to sell the product in Japan. Companies are also carrying out strategic collaborations and acquisitions to strengthen their portfolio. In 2019, Baxter announced acquisition of Seprafilm – Sanofi’s adhesion barrier product line – for US$ 350 million, which concluded in 2020. This acquisition will complement Baxter’s sealant and haemostat portfolio and provide optimized patient care.
Few of the key players in the adhesion barrier market include Johnson & Johnson, Leader Biomedical, Baxter International, Anika Therapeutics, FzioMed Inc., Integra LifeSciences Holdings Corporation, Sanofi, PlantTec Medical GmbH and Ethicon US.
Global Adhesion Barrier Market is Segmented as Below:
By Type
By Delivery Mode
By Application
By Region
Key Elements Included In The Study: Global Adhesion Barrier Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Disclaimer:
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.
View Methodology